ASTRAZEN - Swing Trade Analysis with AI Signals
Last Updated Time : 20 Dec 25, 07:00 am
Back to Swing Trade ListSwing Trade Rating: 3.4
| Stock Code | ASTRAZEN | Market Cap | 22,729 Cr. | Current Price | 9,092 ₹ | High / Low | 10,691 ₹ |
| Stock P/E | 98.3 | Book Value | 320 ₹ | Dividend Yield | 0.35 % | ROCE | 33.4 % |
| ROE | 23.6 % | Face Value | 2.00 ₹ | DMA 50 | 9,112 ₹ | DMA 200 | 8,663 ₹ |
| Chg in FII Hold | -0.29 % | Chg in DII Hold | 0.71 % | PAT Qtr | 58.1 Cr. | PAT Prev Qtr | 56.1 Cr. |
| RSI | 48.2 | MACD | -26.0 | Volume | 3,969 | Avg Vol 1Wk | 2,962 |
| Low price | 6,301 ₹ | High price | 10,691 ₹ | PEG Ratio | 2.27 | Debt to equity | 0.04 |
| 52w Index | 63.6 % | Qtr Profit Var | 51.3 % | EPS | 79.7 ₹ | Industry PE | 30.6 |
📊 ASTRAZEN shows moderate potential for swing trading. The RSI at 48.2 suggests neutral momentum, while the MACD (-26.0) indicates short-term bearishness. The price is near the 50 DMA (9,112 ₹) and above the 200 DMA (8,663 ₹), reflecting medium-term strength despite current weakness. Optimal entry would be near 8,950–9,050 ₹, close to support levels. If already holding, consider exiting near 9,400–9,600 ₹, with potential extension to 9,800 ₹ if momentum improves.
✅ Positive
- 📈 Strong ROCE (33.4%) and ROE (23.6%) highlight efficient capital use.
- 💹 DII holdings increased (+0.71%), showing domestic investor confidence.
- 📊 Quarterly profit growth (+51.3%) reflects strong earnings momentum.
- 💰 Low debt-to-equity ratio (0.04) indicates financial stability.
- 💹 52-week gain of 63.6% highlights strong long-term investor interest.
⚠️ Limitation
- 📉 High P/E (98.3) compared to industry average (30.6), suggesting stretched valuation.
- 📉 PEG ratio of 2.27 signals overvaluation relative to growth.
- 📉 FII holdings decreased (-0.29%), reflecting reduced foreign investor interest.
- 📉 Dividend yield of 0.35% is modest compared to peers.
🚨 Company Negative News
Valuation remains stretched with a very high P/E and PEG ratio. Technical indicators show short-term bearishness with negative MACD. Foreign institutional investors reduced holdings, adding caution.
🌟 Company Positive News
Strong fundamentals with high ROCE and ROE, robust quarterly profit growth, and domestic institutional inflows. Low debt levels provide resilience, and long-term performance remains impressive with over 63% gain in the past year.
🏭 Industry
The pharmaceutical industry trades at an average P/E of 30.6, while ASTRAZEN trades at 98.3, making it significantly more expensive compared to peers. Sector demand remains strong, supporting medium-term opportunities despite valuation concerns.
📌 Conclusion
ASTRAZEN is a moderate candidate for swing trading. Entry near 8,950–9,050 ₹ offers a favorable risk-reward setup. Exit strategy should target 9,400–9,600 ₹, with potential upside toward 9,800 ₹ if momentum strengthens. Traders should remain cautious due to stretched valuations and weak technicals but can benefit from strong fundamentals and sector support.
I can also outline a stop-loss level around 8,800 ₹ to help manage downside risk more effectively.
Back to Swing Trade ListNIFTY 50 - Today Top Swing Trade Stock Picks
NEXT 50 - Today Top Swing Trade Stock Picks
MIDCAP - Today Top Swing Trade Stock Picks
SMALLCAP - Today Top Swing Trade Stock Picks